Pacific Biosciences of California, Inc.

PACB

NASDAQ

Healthcare

Medical - Devices

Menlo Park, CA, US575 employeespacb.com

$1.33

-0.01(-1.11%)

Mkt Cap $403M

$0.91

$2.67

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Product (47%), Instrument (24.7%), Consumable (22.2%).

8-K

Pacific Biosciences of California, Inc. announced Q4 and full year 2025 financial results on February 12, 2026, reporting Q4 revenue of $44.6 million (up 14% YoY) and full year revenue of $160.0 million, with record consumables revenue and strengthened balance sheet from $48.1 million short-read asset sale.

$403M

Market Cap

$160M

Revenue

-$547M

Net Income

Employees575

Fundamentals

How The Business Makes Money

Revenue by Segment

Product47%($456M)

Instrument24.7%($240M)

Consumable22.2%($216M)

Service And Other6.1%($59M)

Revenue by Geography

Americas33.8%($257M)

US32.3%($246M)

Asia Pacific18.2%($138M)

EMEA15.7%($119M)

Activity

What Changed Recently

Management Change

Mar 5, 2026

(c)(2) of Form 8-K regarding Mr. Gibson is included in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 23, 2025, and is

Management Change

Mar 4, 2026

. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On March 3,

Management Change

Feb 2, 2026

. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On February

Financial Results

Feb 11, 2026

). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934

Material Agreement

Feb 1, 2026

. ITEM 2.01. COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS. On January 30, 2026, Pacific Biosciences of California, Inc. (the “Company”) completed the disp

Peer Companies

Company	Price	Change	Market Cap	P/E
IOVAIovance Biotherapeutics, ...	$3.43	-0.58%	$1.1B	-3.8
BFLYButterfly Network, Inc.	$4.10	+0.24%	$1.0B	-13.7
IARTIntegra LifeSciences Hold...	$9.55	-0.16%	$745M	-1.4
AVNSAvanos Medical, Inc.	$13.93	-1.17%	$648M	-9.2
SIBNSI-BONE, Inc.	$13.15	+1.08%	$581M	-29.9
FLGTFulgent Genetics, Inc.	$16.88	+2.68%	$527M	-8.3
OFIXOrthofix Medical Inc.	$11.53	-0.73%	$463M	-5.2
DNAGinkgo Bioworks Holdings,...	$6.93	+2.14%	$429M	-1.2

Analyst View

Company Profile

CIK0001299130

ISINUS69404D1081

CUSIP69404D108

Phone650 521 8000

Address1305 O’Brien Drive, Menlo Park, CA, 94025, US

SEC EDGAR